Literature DB >> 26252121

NCI-MATCH pairs tumor mutations with matching drugs.

Vicki Brower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26252121     DOI： 10.1038/nbt0815-790

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Obama catapults patient-empowered Precision Medicine.

Authors:  Jeffrey L Fox
Journal:  Nat Biotechnol       Date:  2015-04       Impact factor: 54.908

2.  Master Protocol for squamous cell lung cancer readies for launch.

Authors:  Jeffrey L Fox
Journal:  Nat Biotechnol       Date:  2014-02       Impact factor: 54.908

3.  Trial watch: Lung cancer trial aims to bolster personalized medicine.

Authors:  Charlotte Harrison
Journal:  Nat Rev Drug Discov       Date:  2014-06       Impact factor: 84.694
  3 in total
  15 in total

1.  Loxo TRK inhibitor data wows oncologists.

Authors:  Elie Dolgin
Journal:  Nat Biotechnol       Date:  2017-08-08       Impact factor: 54.908

2.  Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial.

Authors:  Chih-Jian Lih; Robin D Harrington; David J Sims; Kneshay N Harper; Courtney H Bouk; Vivekananda Datta; Jonathan Yau; Rajesh R Singh; Mark J Routbort; Rajyalakshmi Luthra; Keyur P Patel; Geeta S Mantha; Savitri Krishnamurthy; Karyn Ronski; Zenta Walther; Karin E Finberg; Sandra Canosa; Hayley Robinson; Amelia Raymond; Long P Le; Lisa M McShane; Eric C Polley; Barbara A Conley; James H Doroshow; A John Iafrate; Jeffrey L Sklar; Stanley R Hamilton; P Mickey Williams
Journal:  J Mol Diagn       Date:  2017-02-07       Impact factor: 5.568

Review 3.  Operationalization of Next-Generation Sequencing and Decision Support for Precision Oncology.

Authors:  Jia Zeng; Amber Johnson; Md Abu Shufean; Michael Kahle; Dong Yang; Scott E Woodman; Thuy Vu; Shhyam Moorthy; Vijaykumar Holla; Funda Meric-Bernstam
Journal:  JCO Clin Cancer Inform       Date:  2019-09

Review 4.  Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.

Authors:  Joseph D Khoury; Wei-Lien Wang; Victor G Prieto; L Jeffrey Medeiros; Neda Kalhor; Meera Hameed; Russell Broaddus; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2017-08-24       Impact factor: 12.531

Review 5.  Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.

Authors:  Keith T Schmidt; Cindy H Chau; Douglas K Price; William D Figg
Journal:  J Clin Pharmacol       Date:  2016-06-17       Impact factor: 3.126

6.  Molecular determinants of drug response in TNBC cell lines.

Authors:  Nathan M Merrill; Eric J Lachacz; Nathalie M Vandecan; Peter J Ulintz; Liwei Bao; John P Lloyd; Joel A Yates; Aki Morikawa; Sofia D Merajver; Matthew B Soellner
Journal:  Breast Cancer Res Treat       Date:  2019-10-26       Impact factor: 4.872

7.  Deep learning of pharmacogenomics resources: moving towards precision oncology.

Authors:  Yu-Chiao Chiu; Hung-I Harry Chen; Aparna Gorthi; Milad Mostavi; Siyuan Zheng; Yufei Huang; Yidong Chen
Journal:  Brief Bioinform       Date:  2020-12-01       Impact factor: 11.622

8.  Precision oncology in the age of integrative genomics.

Authors:  Chandan Kumar-Sinha; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2018-01-10       Impact factor: 54.908

Review 9.  [Personalized oncology].

Authors:  C Heining; P Horak; S Gröschel; H Glimm; S Fröhling
Journal:  Radiologe       Date:  2017-10       Impact factor: 0.635

10.  Getting Past No in Cancer Care.

Authors:  Michael Kolodziej
Journal:  Oncologist       Date:  2016-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.